NASDAQ: GOCO - GoHealth, Inc.

Yield per half year: +30.58%
Dividend yield: 0.00%
Sector: Healthcare

Company Analysis GoHealth, Inc.

Download the report: word Word pdf PDF

1. Summary

Advantages

  • Price (14.71 $) is less than fair price (16.57 $)
  • The stock's return over the last year (39.87%) is higher than the sector average (-12.5%).

Disadvantages

  • Dividends (0%) are below the sector average (0.541%).
  • Current debt level 33.58% has increased over 5 years from 18.23%.
  • The company's current efficiency (ROE=-27.38%) is lower than the sector average (ROE=9.61%)

Similar companies

DENTSPLY SIRONA

Alexion

Amgen

ABIOMED

2. Share price and performance

2.1. Share price

2.2. News

No news yet

2.3. Market efficiency

GoHealth, Inc. Healthcare Index
7 days 23.1% 2.5% -0.6%
90 days 53.6% -17.8% 9.1%
1 year 39.9% -12.5% 30.2%

GOCO vs Sector: GoHealth, Inc. has outperformed the "Healthcare" sector by 52.37% over the past year.

GOCO vs Market: GoHealth, Inc. has outperformed the market by 9.64% over the past year.

Stable price: GOCO is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.

Long period: GOCO with weekly volatility of 0.7667% over the past year.

3. Summary of the report

3.1. General

P/E: 22.1
P/S: 0.1835

3.2. Revenue

EPS -6.81
ROE -27.38%
ROA -4.22%
ROIC -18.86%
Ebitda margin 5.26%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Below fair price: The current price (14.71 $) is lower than the fair price (16.57 $).

Price not significantly lower than the fair price: The current price (14.71 $) is slightly lower than the fair price by 12.6%.

4.2. P/E

P/E vs Sector: The company's P/E (22.1) is lower than that of the sector as a whole (48.77).

P/E vs Market: The company's P/E (22.1) is lower than that of the market as a whole (49.04).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (0.3324) is lower than that of the sector as a whole (4.83).

P/BV vs Market: The company's P/BV (0.3324) is lower than that of the market as a whole (3.17).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (0.1835) is lower than that of the sector as a whole (33.77).

P/S vs Market: The company's P/S indicator (0.1835) is lower than that of the market as a whole (10.24).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (16.45) is higher than that of the sector as a whole (-22.17).

EV/Ebitda vs Market: The company's EV/Ebitda (16.45) is lower than that of the market as a whole (28.32).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Negative and has fallen by -6.98% over the last 5 years.

Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-6.98%).

Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (4135.44%).

5.4. ROE

ROE vs Sector: The company's ROE (-27.38%) is lower than that of the sector as a whole (9.61%).

ROE vs Market: The company's ROE (-27.38%) is lower than that of the market as a whole (10.71%).

5.5. ROA

ROA vs Sector: The company's ROA (-4.22%) is lower than that of the sector as a whole (0.3443%).

ROA vs Market: The company's ROA (-4.22%) is lower than that of the market as a whole (6.47%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (-18.86%) is lower than that of the sector as a whole (7.63%).

ROIC vs Market: The company's ROIC (-18.86%) is lower than that of the market as a whole (10.79%).

6. Finance

6.1. Assets and debt

Debt level: (33.58%) is quite low in relation to assets.

Increasing debt: over 5 years, the debt has increased from 18.23% to 33.58%.

Excess of debt: The debt is not covered by net income, percentage -795.96%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0% is below the average for the sector '0.541%.

7.2. Stability and increase in payments

Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.

Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

Transaction date Insider Type Price Volume Quantity
28.11.2022 CCP III Cayman GP Ltd.
10% Owner
Purchase 10.05 387 116 38 519
28.11.2022 CB Blizzard Holdings C, L.P.
10% Owner
Purchase 10.05 387 116 38 519
25.11.2022 CCP III Cayman GP Ltd.
10% Owner
Purchase 9.03 79 563 8 811
25.11.2022 CB Blizzard Holdings C, L.P.
10% Owner
Purchase 9.03 79 563 8 811

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum GoHealth, Inc.

9.3. Comments